Want to see HK:2563 full AI Analyst Report?

Beijing Biostar Pharmaceuticals Co., Ltd. Class H (2563) Revenue

0 Followers

Beijing Biostar Pharmaceuticals Co., Ltd. Class H Revenue

Beijing Biostar Pharmaceuticals Co., Ltd. Class H had a revenue of 21.16M in the quarter ending Jun 30, 2026, with 1.61%. This bring the company's revenue in the last twelve months to 64.58M, Decreased 23.51%. In the fiscal year ending Dec 31, 2025, Beijing Biostar Pharmaceuticals Co., Ltd. Class H had annual revenue of 37.12M with -52.36% growth.

Revenue (ttm)

64.58M

Revenue Growth

―

P/S Ratio

50.70

Revenue/Employee

HK$276,998

Employees

134

Market Cap

HK$1.88B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	37.12M	-40.80M	-52.36%
Jun 30, 2025	77.92M	4.17M	+5.65%
Dec 31, 2023	73.75M	36.37M	+97.31%
Dec 31, 2022	37.38M	-69.37M	-64.98%
Dec 31, 2021	106.74M	―	+∞%
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―